1. BCR‐ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next‐generation sequencing. Issue 10 (22nd July 2014) Authors: Musilova, Milena; Razga, Filip; Jurcek, Tomas; Jeziskova, Ivana; Borsky, Marek; Nemethova, Veronika; Zackova, Daniela; Culen, Martin; Dvorakova, Dana; Mayer, Jiri; Racil, Zdenek Journal: American journal of hematology Issue: Volume 89:Issue 10(2014:Oct.) Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications. Issue 9 (23rd July 2013) Authors: Pavlik, Tomas; Janousova, Eva; Mayer, Jiri; Indrak, Karel; Jarosova, Marie; Klamova, Hana; Zackova, Daniela; Voglova, Jaroslava; Faber, Edgar; Karas, Michal; Machova Polakova, Katerina; Racil, Zdenek; Demeckova, Eva; Demitrovicova, Ludmila; Tothova, Elena; Chudej, Juraj; Markuljak, Imrich; Cmunt,... Journal: American journal of hematology Issue: Volume 88:Issue 9(2013:Sep.) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice. Issue 1 (2nd January 2021) Authors: Zackova, Daniela; Klamova, Hana; Belohlavkova, Petra; Stejskal, Lukas; Necasova, Tereza; Semerad, Lukas; Weinbergerova, Barbora; Srbova, Dana; Voglova, Jaroslava; Cicatkova, Petra; Sustkova, Zuzana; Hornak, Tomas; Baranova, Jana; Prochazkova, Jirina; Mayer, Jiri Journal: Leukemia & lymphoma Issue: Volume 62:Issue 1(2021) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. Issue 10 (October 2013) Authors: Zackova, Daniela; Klamova, Hana; Muzik, Jan; Cmunt, Eduard; Racil, Zdenek; Machova Polakova, Katerina; Dvorakova, Dana; Jurcek, Tomas; Razga, Filip; Cetkovsky, Petr; Dusek, Ladislav; Mayer, Jiri Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients. Issue 5 (16th April 2021) Authors: Folta, Adam; Jurcek, Tomas; Kubesova, Blanka; Zackova, Daniela; Semerad, Lukas; Mayer, Jiri; Jeziskova, Ivana Journal: Leukemia & lymphoma Issue: Volume 62:Issue 5(2021) Page Start: 1239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow‐up. (1st July 2021) Authors: Romzova, Marianna; Smitalova, Dagmar; Hynst, Jakub; Tom, Nikola; Loja, Tomas; Herudkova, Zdenka; Jurcek, Tomas; Stejskal, Lukas; Zackova, Daniela; Mayer, Jiri; Racil, Zdenek; Culen, Martin Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. Issue 10 (31st August 2018) Authors: Racil, Zdenek; Koritakova, Eva; Sacha, Tomasz; Klamova, Hana; Belohlavkova, Petra; Faber, Edgar; Rea, Delphine; Malaskova, Ludmila; Prochazkova, Jirina; Zackova, Daniela; Voglova, Jaroslava; Wącław, Joanna; Cetkovsky, Petr; Zak, Pavel; Mayer, Jiri Journal: American journal of hematology Issue: Volume 93:Issue 10(2018:Oct.) Page Start: E342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia. Issue 2 (20th August 2013) Authors: Racil, Zdenek; Razga, Filip; Klamova, Hana; Voglova, Jaroslava; Belohlavkova, Petra; Malaskova, Ludmila; Potesil, David; Muzik, Jan; Zackova, Daniela; Polakova, Katerina Machova; Zdrahal, Zbynek; Malakova, Jana; Suttnar, Jiri; Dyr, Jan; Mayer, Jiri Journal: Hematological oncology Issue: Volume 32:Issue 2(2014:Jun.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel Illumina‐based next generation sequencing approach with one‐round amplification provides early and reliable detection of BCR‐ABL1 kinase domain mutations in chronic myeloid leukemia. (9th February 2020) Authors: Romzova, Marianna; Smitalova, Dagmar; Tom, Nikola; Jurcek, Tomas; Culen, Martin; Zackova, Daniela; Mayer, Jiri; Racil, Zdenek Journal: British journal of haematology Issue: Volume 189:Number 3(2020) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. Issue 11 (14th September 2019) Authors: Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson‐Strömberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert‐Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, An... Journal: American journal of hematology Issue: Volume 94:Issue 11(2019:Nov.) Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗